Cockayne Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Mutations in Cockayne syndrome (CS) A and B genes (CSA and CSB) result in a rare genetic disease that affects the development and homeostasis of a wide range of tissues and organs.
|
22032989 |
2011 |
Cockayne Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Deficiency in TC-NER associates with mutations in the CSA and CSB genes giving rise to the rare human disorder Cockayne syndrome (CS).
|
21622031 |
2011 |
Cockayne Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Mutations of the ERCC6 and ERCC8 genes are the predominant cause of the Cockayne syndrome, whereby the ERCC6 gene mutation makes up approximately 70% of the cases.
|
21477668 |
2011 |
Cockayne Syndrome
|
0.800 |
Biomarker
|
disease |
BEFREE |
Mutation update for the CSB/ERCC6 and CSA/ERCC8 genes involved in Cockayne syndrome.
|
19894250 |
2010 |
Cockayne Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
High carriers frequency of an apparently ancient founder mutation p.Tyr322X in the ERCC8 gene responsible for Cockayne syndrome among Christian Arabs in Northern Israel.
|
21108394 |
2010 |
Cockayne Syndrome
|
0.800 |
Biomarker
|
disease |
BEFREE |
Expression of the p.trp361cys-mutated CSA cDNA increases the resistance of cells from a CS-A patient to oxidative stress, but does not correct their UV hypersensitivity.
|
19329487 |
2009 |
Cockayne Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Cockayne syndrome (CS) is mainly caused by mutations in the Cockayne syndrome group A or B (CSA or CSB) genes which are required for a sub-pathway of nucleotide excision repair entitled transcription coupled repair.
|
17084038 |
2007 |
Cockayne Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Cockayne syndrome (CS) is a progressive childhood neurodegenerative disorder associated with a DNA repair defect caused by mutations in either of two genes, CSA and CSB.
|
17055654 |
2007 |
Cockayne Syndrome
|
0.800 |
Biomarker
|
disease |
BEFREE |
CSA-dependent degradation of CSB by the ubiquitin-proteasome pathway establishes a link between complementation factors of the Cockayne syndrome.
|
16751180 |
2006 |
Cockayne Syndrome
|
0.800 |
Biomarker
|
disease |
LHGDN |
Cockayne syndrome A and B proteins differentially regulate recruitment of chromatin remodeling and repair factors to stalled RNA polymerase II in vivo.
|
16916636 |
2006 |
Cockayne Syndrome
|
0.800 |
Biomarker
|
disease |
LHGDN |
CSA-dependent degradation of CSB by the ubiquitin-proteasome pathway establishes a link between complementation factors of the Cockayne syndrome.
|
16751180 |
2006 |
Cockayne Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Mutation of CSB, CSA, or the TFIIH helicases XPB and XPD can also cause defective TCR and CS.
|
16246722 |
2005 |
Cockayne Syndrome
|
0.800 |
GeneticVariation
|
disease |
LHGDN |
Mutation of CSB, CSA, or the TFIIH helicases XPB and XPD can also cause defective TCR and CS.
|
16246722 |
2005 |
Cockayne Syndrome
|
0.800 |
Biomarker
|
disease |
BEFREE |
These findings not only uncover a clear difference in oxidative DNA damage sensitivity between CSA- and CSB-deficient cell lines and mice but also show that sensitivity to oxidative DNA damage is not a uniform characteristic of Cockayne syndrome.
|
15340056 |
2004 |
Cockayne Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
These data suggest that multiple splicing variant forms of CSA mRNA, in the absence of the full-length form of the mRNA, are associated with CS.
|
15211661 |
2004 |
Cockayne Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
The devastating genetic disorder Cockayne syndrome (CS) arises from mutations in the CSA and CSB genes.
|
14639525 |
2003 |
Cockayne Syndrome
|
0.800 |
Biomarker
|
disease |
BEFREE |
The CSA and CSB genes responsible for CS are both components of complexes associated with RNA polymerase II and their role is thought to be in assisting polII in dealing with transcription blocks.
|
14726016 |
2003 |
Cockayne Syndrome
|
0.800 |
Biomarker
|
disease |
MGD |
UVB radiation-induced cancer predisposition in Cockayne syndrome group A (Csa) mutant mice.
|
12509261 |
2002 |
Cockayne Syndrome
|
0.800 |
Biomarker
|
disease |
BEFREE |
Cockayne syndrome (CS) is a segmental premature aging syndrome in humans that has two complementation groups, CSA and CSB.
|
12483520 |
2002 |
Cockayne Syndrome
|
0.800 |
Biomarker
|
disease |
BEFREE |
The predicted structures for ALDP and CSA, proteins responsible for adrenoleukodystrophy and the Cockayne syndrome, respectively, were analyzed to elucidate the molecular basis of disease mutations.
|
11898854 |
2001 |
Cockayne Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
The abnormalities in CS are associated with mutations in the CSA or CSB genes.
|
10739753 |
2000 |
Cockayne Syndrome
|
0.800 |
Biomarker
|
disease |
BEFREE |
The two gene products of the CS complementation groups (CSA and CSB) have been implicated in the preferential repair of the transcribed strand of human genes.
|
9685618 |
1998 |
Cockayne Syndrome
|
0.800 |
Biomarker
|
disease |
BEFREE |
Rodent complementation group 8 (ERCC8) corresponds to Cockayne syndrome complementation group A.
|
8596535 |
1996 |